{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T04:10:41Z","timestamp":1770351041932,"version":"3.49.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.clinthera.2011.11.006","type":"journal-article","created":{"date-parts":[[2011,12,14]],"date-time":"2011-12-14T12:30:34Z","timestamp":1323865834000},"page":"37-55","source":"Crossref","is-referenced-by-count":24,"title":["Estradiol Valerate\/Dienogest: A Novel Combined Oral Contraceptive"],"prefix":"10.1016","volume":"34","author":[{"given":"Laura M.","family":"Borgelt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chad W.","family":"Martell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2011.11.006_bib1","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.3109\/13625187.2010.513071","article-title":"History of oral contraception","volume":"15","author":"Dhont","year":"2010","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.clinthera.2011.11.006_bib2","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ajog.2005.06.010","article-title":"Chemical birth of the pill","volume":"194","author":"Djerassi","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clinthera.2011.11.006_bib3","series-title":"Contraceptive Technology","first-page":"193","article-title":"Combined oral contraceptives","author":"Nelson","year":"2007"},{"key":"10.1016\/j.clinthera.2011.11.006_bib4","first-page":"6","article-title":"In the news, now on the shelf: a novel estradiol-based OC","volume":"22","author":"Barbieri","year":"2010","journal-title":"OBG Management"},{"key":"10.1016\/j.clinthera.2011.11.006_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/13625180903585431","article-title":"After 50 years of ethinylestradiol, another oestrogen in combined oral contraceptives","volume":"15","author":"Alsina","year":"2010","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.clinthera.2011.11.006_bib6","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0940-2993(98)80034-1","article-title":"Approaches to the replacement of ethinylestradiol by natural 17beta-estradiol in combined oral contraceptives","volume":"50","author":"Hoffmann","year":"1998","journal-title":"Exp Toxicol Pathol"},{"key":"10.1016\/j.clinthera.2011.11.006_bib7","first-page":"105","article-title":"Alternatives of the replacement of ethinylestradiol by natural 17beta-estradiol in dienogest-containing oral contraceptives","volume":"35","author":"Hoffmann","year":"1999","journal-title":"Drugs Today"},{"key":"10.1016\/j.clinthera.2011.11.006_bib8","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.contraception.2010.04.004","article-title":"The use of newer progestins for contraception","volume":"82","author":"Sitruk-Ware","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.clinthera.2011.11.006_bib9","series-title":"Natazia (estradiol valerate\/dienogest)","year":"2010"},{"key":"10.1016\/j.clinthera.2011.11.006_bib10","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.contraception.2004.12.012","article-title":"Rationale for decreasing the number of days of the hormone-free interval with use of low-dose oral contraceptive formulations","volume":"71","author":"Mishell","year":"2005","journal-title":"Contraception"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2011.11.006_bib11","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3109\/13625187.2010.529969","article-title":"New regimens with combined oral contraceptive pills\u2014moving away from traditional 21\/7 cycles","volume":"15","author":"Read","year":"2010","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.clinthera.2011.11.006_bib13","series-title":"Clinical Gynecologic Endocrinology and Infertility","first-page":"861","article-title":"Oral contraception","author":"Speroff","year":"2005"},{"key":"10.1016\/j.clinthera.2011.11.006_bib14","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1517\/14656561003724713","article-title":"Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest","volume":"11","author":"Jensen","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.clinthera.2011.11.006_bib15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/13625180902850039","article-title":"Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest","volume":"14","author":"Zeun","year":"2009","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.clinthera.2011.11.006_bib16","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2165\/11536320-000000000-00000","article-title":"Ethinylestradiol\/dienogest in oral contraception","volume":"70","author":"Perez-Campos","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2011.11.006_bib17","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.2165\/11202820-000000000-00000","article-title":"Estradiol valerate\/dienogest: in oral contraception","volume":"69","author":"Hoy","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2011.11.006_bib18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0378-5122(82)90064-0","article-title":"Pharmacokinetic and pharmacological features of oestradiol valerate","volume":"4","author":"Dusterberg","year":"1982","journal-title":"Maturitas"},{"key":"10.1016\/j.clinthera.2011.11.006_bib19","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.contraception.2008.05.004","article-title":"Ovulation inhibition with four variations of a four-phasic estradiol valerate\/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies","volume":"78","author":"Endrikat","year":"2008","journal-title":"Contraception"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2011.11.006_bib20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/13625189909085259","article-title":"The pharmacological profile of dienogest","volume":"4","author":"Oettel","year":"1999","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.clinthera.2011.11.006_bib21","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0029-7844(01)01532-0","article-title":"Drug interactions between oral contraceptives and antibiotics","volume":"98","author":"Dickinson","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clinthera.2011.11.006_bib22","first-page":"102","article-title":"Pill method failure","volume":"100","author":"Sparrow","year":"1987","journal-title":"N Z Med J"},{"key":"10.1016\/j.clinthera.2011.11.006_bib23","first-page":"41","article-title":"Pill failure and non-use of secondary precautions","volume":"18","author":"Kakouris","year":"1992","journal-title":"Br J Fam Plan"},{"key":"10.1016\/j.clinthera.2011.11.006_bib24","doi-asserted-by":"crossref","first-page":"549","DOI":"10.5694\/j.1326-5377.1989.tb136691.x","article-title":"Inadvertent pregnancies in oral contraceptive users","volume":"150","author":"Kovacs","year":"1989","journal-title":"Med J Aust"},{"key":"10.1016\/j.clinthera.2011.11.006_bib25","first-page":"416","article-title":"The effect of doxycycline on serum levels of ethinyl estradiol, norethindrone, and endogenous progesterone","volume":"77","author":"Neely","year":"1991","journal-title":"Obstet Gynecol"},{"issue":"1 Pt 1","key":"10.1016\/j.clinthera.2011.11.006_bib26","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/0002-9378(91)90617-Z","article-title":"The effect of tetracycline on levels of oral contraceptives","volume":"164","author":"Murphy","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clinthera.2011.11.006_bib27","first-page":"33","article-title":"The effect of ampicillin on oral contraceptive effectiveness","volume":"55","author":"Friedman","year":"1980","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clinthera.2011.11.006_bib28","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0010-7824(93)90025-3","article-title":"Ultrasound evaluation of ovarian activity under oral contraceptives","volume":"47","author":"Hoogland","year":"1993","journal-title":"Contraception"},{"key":"10.1016\/j.clinthera.2011.11.006_bib29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0010-7824(96)00183-7","article-title":"Inhibition of ovulation by an oral contraceptive containing 100 micrograms levonorgestrel in combination with 20 micrograms ethinylestradiol","volume":"54","author":"Spona","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.clinthera.2011.11.006_bib30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejogrb.2009.11.001","article-title":"Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate\/dienogest): a Phase III trial","volume":"149","author":"Palacios","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2011.11.006_bib31","first-page":"9","article-title":"The safety and contraceptive efficacy of a 24-day low-dose oral contraceptive regimen containing gestodene 60 microg and ethinylestradiol 15 microg","volume":"4","year":"1999","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.clinthera.2011.11.006_bib32","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.contraception.2006.07.004","article-title":"Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone","volume":"74","author":"Ahrendt","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.clinthera.2011.11.006_bib33","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.contraception.2004.05.013","article-title":"Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenone","volume":"70","author":"Bachmann","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.clinthera.2011.11.006_bib34","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0010-7824(80)90010-4","article-title":"A randomized, double-blind study of two combined oral contraceptives containing the same progestogen, but different estrogens","volume":"21","year":"1980","journal-title":"Contraception"},{"key":"10.1016\/j.clinthera.2011.11.006_bib35","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1471-0528.1979.tb11276.x","article-title":"Clinical trial of a new oral contraceptive pill containing the natural oestrogen 17 beta-oestradiol","volume":"86","author":"Astedt","year":"1979","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.clinthera.2011.11.006_bib36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0378-5122(94)00856-3","article-title":"Oral contraceptive containing natural estradiol for premenopausal women","volume":"21","author":"Hirvonen","year":"1995","journal-title":"Maturitas"},{"key":"10.1016\/j.clinthera.2011.11.006_bib37","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0140-6736(79)91525-3","article-title":"Natural oestrogens for oral contraception","volume":"2","author":"Serup","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2011.11.006_bib38","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.contraception.2009.03.018","article-title":"Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate\/dienogest and ethinyl estradiol\/levonorgestrel","volume":"80","author":"Ahrendt","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.clinthera.2011.11.006_bib39","unstructured":"Nelson A, Sampson-Landers C, Parke S, Jensen JT. Efficacy of estradiol valerate\/dienogest OC: results of 3 large studies in North America and Europe. Abstract and poster presented at: 57th Annual Clinical Meeting of the American Congress of Obstetricians and Gynecologists; May 2-6, 2009; Chicago, Ill"},{"key":"10.1016\/j.clinthera.2011.11.006_bib40","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejogrb.2010.12.037","article-title":"Contraceptive efficacy of a combined oral contraceptive containing ethinylestradiol 20 mcg\/drosperinone 3 mg administered in a 24\/4 regimen: a pooled analysis of four open-label studies","volume":"155","author":"Anttila","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.clinthera.2011.11.006_bib41","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.2165\/00003495-200565160-00007","article-title":"Low-dose ethinylestradiol\/levonorgestrel","volume":"65","author":"Dando","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2011.11.006_bib42","first-page":"127","article-title":"Endometrial safety of an oral contraceptive containing estradiol valerate and dienogest","volume":"3","author":"Bitzer","year":"2011","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.clinthera.2011.11.006_bib43","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0015-0282(16)56210-4","article-title":"Ovulation inhibition with a combined oral contraceptive containing 1 mg micronized 17 beta-estradiol","volume":"60","author":"Wenzl","year":"1993","journal-title":"Fertil Steril"},{"key":"10.1016\/j.clinthera.2011.11.006_bib44","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3109\/00016348709015732","article-title":"Ovulation inhibition with 17 beta-estradiol cyclo-octyl acetate and desogestrel","volume":"66","author":"Schubert","year":"1987","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2011.11.006_bib45","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.1016\/S0020-7292(09)60691-3","volume":"107","author":"Fraser","year":"2009","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.clinthera.2011.11.006_bib46","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/AOG.0b013e3182118ac3","article-title":"Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: a randomized controlled trial","volume":"117","author":"Jensen","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clinthera.2011.11.006_bib47","doi-asserted-by":"crossref","unstructured":"Wasiak R, Filonenko A, Jensen J, Law A, Jeddi M, Stull D. Impact of estradiol valerate\/dienogest (E2V\/DNG) on work productivity (WP) and activities of daily living (ADL) impairment in North American women with heavy and\/or prolonged menstrual bleeding (HPMP). Paper presented at: American Society for Reproductive Medicine (ASRM) 66th Annual Meeting; October 23\u201327, 2010; Denver, Colo.","DOI":"10.1016\/j.fertnstert.2010.07.832"},{"key":"10.1016\/j.clinthera.2011.11.006_bib48","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.contraception.2004.03.004","article-title":"Effect of four oral contraceptives on hemostatic parameters","volume":"70","author":"Wiegratz","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.clinthera.2011.11.006_bib49","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0010-7824(02)00436-5","article-title":"Effect of four different oral contraceptives on various sex hormones and serum-binding globulins","volume":"67","author":"Wiegratz","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.clinthera.2011.11.006_bib50","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0010-7824(01)00310-9","article-title":"Effect of dienogest-containing oral contraceptives on lipid metabolism","volume":"65","author":"Wiegratz","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.clinthera.2011.11.006_bib51","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0010-7824(03)00006-4","article-title":"Effect of four oral contraceptives on thyroid hormones, adrenal and blood pressure parameters","volume":"67","author":"Wiegratz","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.clinthera.2011.11.006_bib52","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/11591200-000000000-00000","article-title":"Hemostatic effects of a novel estradiol-based oral contraceptive: an open-label, randomized, crossover study of estradiol valerate\/dienogest versus ethinylestradiol\/levonorgestrel","volume":"11","author":"Klipping","year":"2011","journal-title":"Drugs R D"},{"key":"10.1016\/j.clinthera.2011.11.006_bib54","doi-asserted-by":"crossref","first-page":"b2921","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study","volume":"339","author":"van Hylckama Vlieg","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2011.11.006_bib55","series-title":"Contraceptive Technology","first-page":"699","article-title":"Menopause and perimenopausal health","author":"Nelson","year":"2007"},{"issue":"2 Pt 2","key":"10.1016\/j.clinthera.2011.11.006_bib56","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0002-9378(99)70718-0","article-title":"Causes and consequences of oral contraceptive noncompliance","volume":"180","author":"Rosenberg","year":"1999","journal-title":"Am J Obstet Gynecol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811007235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811007235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T20:38:58Z","timestamp":1593376738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291811007235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0149291811007235"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2011.11.006","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}